Negm A - Search Results

1

Growth Optimization and Secondary Metabolites Evaluation of Anabaena variabilis for Acetylcholinesterase Inhibition Activity.

Refaay DA, Abdel-Hamid MI, Alyamani AA, Abdel Mougib M, Ahmed DM, Negm A, Mowafy AM, Ibrahim AA, Mahmoud RM. Refaay DA, et al. Among authors: negm a. Plants (Basel). 2022 Mar 10;11(6):735. doi: 10.3390/plants11060735. Plants (Basel). 2022. PMID: 35336618 Free PMC article.

2

Combinatorial synthesis, in silico, molecular and biochemical studies of tetrazole-derived organic selenides with increased selectivity against hepatocellular carcinoma.

Shaaban S, Negm A, Ashmawy AM, Ahmed DM, Wessjohann LA. Shaaban S, et al. Among authors: negm a. Eur J Med Chem. 2016 Oct 21;122:55-71. doi: 10.1016/j.ejmech.2016.06.005. Epub 2016 Jun 6. Eur J Med Chem. 2016. PMID: 27343853

3

Capric Acid Behaves Agonistic Effect on Calcitriol to Control Inflammatory Mediators in Colon Cancer Cells.

Negm A, Sedky A, Elsawy H. Negm A, et al. Molecules. 2022 Oct 6;27(19):6624. doi: 10.3390/molecules27196624. Molecules. 2022. PMID: 36235161 Free PMC article.

4

Baicalein and Αlpha-Tocopherol Inhibit Toll-like Receptor Pathways in Cisplatin-Induced Nephrotoxicity.

Awadalla A, Mahdi MR, Zahran MH, Abdelbaset-Ismail A, El-Dosoky M, Negm A. Awadalla A, et al. Among authors: negm a. Molecules. 2022 Mar 28;27(7):2179. doi: 10.3390/molecules27072179. Molecules. 2022. PMID: 35408581 Free PMC article.

5

A Comprehensive Pan-Cancer Analysis Identifies CEP55 as a Potential Oncogene and Novel Therapeutic Target.

Zaki MSA, Eldeen MA, Abdulsahib WK, Shati AA, Alqahtani YA, Al-Qahtani SM, Otifi HM, Asiri A, Hassan HM, Emam Mohammed Ahmed H, Dawood SA, Negm A, Eid RA. Zaki MSA, et al. Among authors: negm a. Diagnostics (Basel). 2023 May 2;13(9):1613. doi: 10.3390/diagnostics13091613. Diagnostics (Basel). 2023. PMID: 37175004 Free PMC article.

6

Repurposed organoselenium tethered amidic acids as apoptosis inducers in melanoma cancer via P53, BAX, caspases-3, 6, 8, 9, BCL-2, MMP2, and MMP9 modulations.

Shaaban S, Althikrallah HA, Negm A, Abo Elmaaty A, Al-Karmalawy AA. Shaaban S, et al. Among authors: negm a. RSC Adv. 2024 Jun 10;14(26):18576-18587. doi: 10.1039/d4ra02944e. eCollection 2024 Jun 6. RSC Adv. 2024. PMID: 38860260 Free PMC article.

7

Design and Synthesis of Quinoxaline Hybrids as Modulators of HIF-1a, VEGF, and p21 for Halting Colorectal Cancer.

Ayoup MS, Rabee AR, Abdel-Hamid H, Amer A, Abu-Serie MM, Ashraf S, Ghareeb DA, Ibrahim RS, Hawsawi MB, Negm A, Ismail MMF. Ayoup MS, et al. Among authors: negm a. ACS Omega. 2024 May 29;9(23):24643-24653. doi: 10.1021/acsomega.4c01075. eCollection 2024 Jun 11. ACS Omega. 2024. PMID: 38882127 Free PMC article.

8

Synthesis, DPPH Radical Scavenging, Cytotoxic Activity, and Apoptosis Induction Efficacy of Novel Thiazoles and Bis-thiazoles.

Negm A, Al-Faiyz YS, Riyadh SM, Sayed AR. Negm A, et al. Curr Org Synth. 2024;21(8):1081-1090. doi: 10.2174/0115701794264504231017113027. Curr Org Synth. 2024. PMID: 37936471

9

Organoselenocyanates and symmetrical diselenides redox modulators: Design, synthesis and biological evaluation.

Shaaban S, Negm A, Sobh MA, Wessjohann LA. Shaaban S, et al. Among authors: negm a. Eur J Med Chem. 2015 Jun 5;97:190-201. doi: 10.1016/j.ejmech.2015.05.002. Epub 2015 May 4. Eur J Med Chem. 2015. PMID: 25969171

10

Chemotherapeutic agents for the treatment of hepatocellular carcinoma: efficacy and mode of action.

Shaaban S, Negm A, Ibrahim EE, Elrazak AA. Shaaban S, et al. Among authors: negm a. Oncol Rev. 2014 May 28;8(1):246. doi: 10.4081/oncol.2014.246. eCollection 2014 Mar 17. Oncol Rev. 2014. PMID: 25992234 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

165 results

Search Page

Filters